444
Views
40
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Potential prognostic and therapeutic role for angiogenesis markers in laryngeal carcinoma

, &
Pages 574-582 | Received 25 Oct 2011, Accepted 11 Dec 2011, Published online: 12 Apr 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Ziyan Li, Rui Liu & Yi Lv. (2023) ICPMS based multiplexed bioassay: Principles, approaches and progresses. Applied Spectroscopy Reviews 58:1, pages 39-64.
Read now
Xiaoyan Yin, Jingmiao Wang, Chunguang Shan, Qiaojing Jia, Yanrui Bian & Haizhong Zhang. (2022) Circular RNA ZNF609 promotes laryngeal squamous cell carcinoma progression by upregulating epidermal growth factor receptor via sponging microRNA-134-5p. Bioengineered 13:3, pages 6929-6941.
Read now
Kexing Lyu, Yun Li, Yang Xu, Huijun Yue, Yihui Wen, Tesi Liu, Siyu Chen, Qihong Liu, Weiqiang Yang, Xiaolin Zhu, Zhangfeng Wang, Liping Chai, Weiping Wen, Chunwei Li & Wenbin Lei. (2020) Using RNA sequencing to identify a putative lncRNA-associated ceRNA network in laryngeal squamous cell carcinoma. RNA Biology 17:7, pages 977-989.
Read now

Articles from other publishers (37)

Lara Alessandrini, Laura Astolfi, Antonio Daloiso, Marta Sbaraglia, Tiziana Mondello, Elisabetta Zanoletti, Leonardo Franz & Gino Marioni. (2023) Diagnostic, Prognostic, and Therapeutic Role for Angiogenesis Markers in Head and Neck Squamous Cell Carcinoma: A Narrative Review. International Journal of Molecular Sciences 24:13, pages 10733.
Crossref
Lara Alessandrini, Marco Ferrari, Stefano Taboni, Marta Sbaraglia, Leonardo Franz, Tommaso Saccardo, Bianca Maria Del Forno, Francesca Agugiaro, Anna Chiara Frigo, Angelo Paolo Dei Tos & Gino Marioni. (2022) Tumor-stroma ratio, neoangiogenesis and prognosis in laryngeal carcinoma. A pilot study on preoperative biopsies and matched surgical specimens. Oral Oncology 132, pages 105982.
Crossref
Lihuo Zhang, Lu Liu, Jundong Zhang & Ping Zhou. (2022) Porcine Fibrin Sealant Promotes Skin Wound Healing in Rats. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-10.
Crossref
Lara Alessandrini, Laura Astolfi, Leonardo Franz, Erica Gentilin, Antonio Mazzoni, Elisabetta Zanoletti & Gino Marioni. (2022) Temporal Bone Squamous Cell Carcinoma: Molecular Markers Involved in Carcinogenesis, Behavior, and Prognosis: A Systematic Review. International Journal of Molecular Sciences 23:9, pages 4536.
Crossref
Michał Żurek, Anna Rzepakowska, Iwona Kotuła, Urszula Demkow & Kazimierz Niemczyk. (2022) Serum expression of Vascular Endothelial-Cadherin, CD44, Human High mobility group B1, Kallikrein 6 proteins in different stages of laryngeal intraepithelial lesions and early glottis cancer. PeerJ 10, pages e13104.
Crossref
Leonardo Franz, Lara Alessandrini, Leonardo Calvanese, Giulia Crosetta, Anna Chiara Frigo & Gino Marioni. (2021) Angiogenesis, programmed death ligand 1 (PD-L1) and immune microenvironment association in laryngeal carcinoma. Pathology 53:7, pages 844-851.
Crossref
Xinxin Guo, Xingchen Meng & Ran Liu. (2021) Prognostic value of microvessel density in esophageal squamous cell carcinoma-a systematic review and meta-analysis. Pathology - Research and Practice 227, pages 153644.
Crossref
Matteo Cavaliere, Antonella Bisogno, Alfonso Scarpa, Alessia D'Urso, Pasquale Marra, Vito Colacurcio, Pietro De Luca, Massimo Ralli, Ettore Cassandro & Claudia Cassandro. (2021) Biomarkers of laryngeal squamous cell carcinoma: a review. Annals of Diagnostic Pathology 54, pages 151787.
Crossref
Xiaoting Wang, Chong Xu, Shengming Wang, Weijun Huang, Yuenan Liu, Xiaoxu Zhang, Niannian Li, Zhenfei Gao, Fan Wang, Nan Zhang, Jian Guan, Hongliang Yi & Feng Liu. (2021) A novel tumor suppressor CECR2 down regulation links glutamine metabolism contributes tumor growth in laryngeal squamous cell carcinoma. Clinical and Translational Oncology 23:9, pages 1942-1954.
Crossref
Qiao Hu, Shang Yong Zhu, Ruo Chuan Liu, Hong Yu Zheng, Hai Mei Lun, Hai Ming Wei & Jing Jin Weng. (2020) Contrast-enhanced ultrasound for the preoperative assessment of laryngeal carcinoma: a preliminary study. Acta Radiologica 62:8, pages 1016-1024.
Crossref
Anna Rzepakowska, Michał Żurek, Jakub Grzybowski, Paweł Pihowicz, Barbara Górnicka, Ewa Osuch-Wójcikiewicz & Kazimierz Niemczyk. (2021) Correlation of narrow band imaging vascular patterns with immunohistological microvessel density in vocal fold lesions. Brazilian Journal of Otorhinolaryngology 87:2, pages 137-144.
Crossref
Giuseppe Brescia, Roberto Padoan, Franco Schiavon, Giacomo Contro, Daniela Parrino, Giulia Tealdo, Mara Felicetti, Anna Chiara Frigo, Lara Alessandrini & Gino Marioni. (2020) Nasal polyps in eosinophilic granulomatosis with polyangiitis: Structured histopathology and CD105 expression. American Journal of Otolaryngology 41:6, pages 102661.
Crossref
Anna Rzepakowska, Michał Żurek, Jakub Grzybowski, Iwona Kotula, Paweł Pihowicz, Barbara Górnicka, Urszula Demkow & Kazimierz Niemczyk. (2020) Serum and tissue expression of neuropilin 1 in precancerous and malignant vocal fold lesions. PLOS ONE 15:10, pages e0239550.
Crossref
Leonardo Franz, Lara Alessandrini, Tommaso Saccardo, Anna Chiara Frigo & Gino Marioni. (2020) CD105- and CD31-assessed microvessel density in laryngeal carcinoma biopsies as a predictor of recurrence after exclusive primary surgery. Annals of Diagnostic Pathology 48, pages 151608.
Crossref
Lara Alessandrini, Leonardo Franz, Giancarlo Ottaviano, Maria Grazia Ghi, Cristiano Lanza, Stella Blandamura & Gino Marioni. (2020) Prognostic role of programmed death ligand 1 (PD-L1) and the immune microenvironment in laryngeal carcinoma. Oral Oncology 108, pages 104836.
Crossref
Leonardo Franz, Giulia Tealdo, Giacomo Contro, Luigia Bandolin, Valentina Carraro, Luciano Giacomelli, Lara Alessandrini, Stella Blandamura & Gino Marioni. (2020) Biological tumor markers (maspin, CD105 , nm23‐H1 ) and disease relapse in laryngeal cancer: cluster analysis . Head & Neck 42:8, pages 2129-2136.
Crossref
Gino Marioni, Leonardo Franz, Giancarlo Ottaviano, Giacomo Contro, Giulia Tealdo, Alessandro Carli, Anna Chiara Frigo, Piero Nicolai & Lara Alessandrini. (2020) Prognostic Significance of CD105- and CD31-Assessed Microvessel Density in Paired Biopsies and Surgical Samples of Laryngeal Carcinoma. Cancers 12:8, pages 2059.
Crossref
Gino Marioni, Giancarlo Ottaviano, Andrea Lovato, Leonardo Franz, Luigia Bandolin, Giacomo Contro, Luciano Giacomelli, Lara Alessandrini, Roberto Stramare, Cosimo de Filippis & Stella Blandamura. (2020) Expression of maspin tumor suppressor and mTOR in laryngeal carcinoma. American Journal of Otolaryngology 41:1, pages 102322.
Crossref
Gino Marioni, Stella Blandamura, Lorenzo Nicolè, Luca Denaro, Diego Cazzador, Chiara Pavone, Luciano Giacomelli, Vincenza Guzzardo, Ambrogio Fassina, Antonio Mazzoni, Domenico D’Avella, Alessandro Martini & Elisabetta Zanoletti. (2019) Endoglin-based assessment of neoangiogenesis in sporadic VIII cranial nerve schwannoma. Pathology - Research and Practice 215:11, pages 152648.
Crossref
Hao‐Sheng Ni, Song‐Qun Hu, Xi Chen, Yi‐Fei Liu, Ting‐Ting Ni & Lei Cheng. (2018) Tra2β silencing suppresses cell proliferation in laryngeal squamous cell carcinoma via inhibiting PI3K/AKT signaling. The Laryngoscope 129:9.
Crossref
Qiancheng Jing, Guo Li, Xiyu Chen, Chao Liu, Shanhong Lu, Hua Zheng, Huiling Ma, Yuexiang Qin, Diekuo Zhang, Shuiting Zhang, Shuling Ren, Donghai Huang, Pingqing Tan, Jie Chen, Yuanzheng Qiu & Yong Liu. (2019) Wnt3a promotes radioresistance via autophagy in squamous cell carcinoma of the head and neck. Journal of Cellular and Molecular Medicine 23:7, pages 4711-4722.
Crossref
Alexey Surov, Hans Jonas Meyer, Anne-Kathrin Höhn, Andreas Wienke, Osama Sabri & Sandra Purz. (2019) 18F-FDG-PET Can Predict Microvessel Density in Head and Neck Squamous Cell Carcinoma. Cancers 11:4, pages 543.
Crossref
Anna Rzepakowska, Michał Żurek, Jakub Grzybowski, Paweł Pihowicz, Barbara Górnicka, Kazimierz Niemczyk & Ewa Osuch-Wójcikiewicz. (2019) Microvascular density and hypoxia-inducible factor in intraepithelial vocal fold lesions. European Archives of Oto-Rhino-Laryngology 276:4, pages 1117-1125.
Crossref
Anke Schlüter, Patrick Weller, Oliver Kanaan, Ivonne Nel, Lukas Heusgen, Benedikt Höing, Pia Haßkamp, Sebastian Zander, Magis Mandapathil, Nina Dominas, Judith Arnolds, Boris A. Stuck, Stephan Lang, Agnes Bankfalvi & Sven Brandau. (2018) CD31 and VEGF are prognostic biomarkers in early-stage, but not in late-stage, laryngeal squamous cell carcinoma. BMC Cancer 18:1.
Crossref
Gino Marioni, Giancarlo Ottaviano, Rosario Marchese-Ragona, Elena Fasanaro, Giulia Tealdo, Claudia Zanotti, Benedetto Randon, Luciano Giacomelli, Edoardo Stellini & Stella Blandamura. (2017) Nuclear survivin expression correlates with endoglin-assessed microvascularisation in laryngeal carcinoma. Journal of Clinical Pathology 70:12, pages 1033-1037.
Crossref
Fengzhi Si, Jie Sun & Chunli Wang. (2017) MicroRNA-138 suppresses cell proliferation in laryngeal squamous cell carcinoma via inhibiting EZH2 and PI3K/AKT signaling. Experimental and Therapeutic Medicine 14:3, pages 1967-1974.
Crossref
Xiao Shi, Wei-ping Hu & Qing-hai Ji. (2017) Development of comprehensive nomograms for evaluating overall and cancer-specific survival of laryngeal squamous cell carcinoma patients treated with neck dissection. Oncotarget 8:18, pages 29722-29740.
Crossref
Gino Marioni, Alessandro Martini, Niccolò Favaretto, Sebastiano Franchella, Rocco Cappellesso, Filippo Marino, Stella Blandamura, Antonio Mazzoni & Elisabetta Zanoletti. (2015) Temporal bone carcinoma: a first glance beyond the conventional clinical and pathological prognostic factors. European Archives of Oto-Rhino-Laryngology 273:10, pages 2903-2910.
Crossref
JIAN-YONG LIU, JIAN-BIN LU & YUE XU. (2016) MicroRNA-153 inhibits the proliferation and invasion of human laryngeal squamous cell carcinoma by targeting KLF5. Experimental and Therapeutic Medicine 11:6, pages 2503-2508.
Crossref
Adrianna Sławińska-Brych, Sylwia Katarzyna Król, Magdalena Dmoszyńska-Graniczka, Barbara Zdzisińska, Andrzej Stepulak & Mariusz Gagoś. (2015) Xanthohumol inhibits cell cycle progression and proliferation of larynx cancer cells in vitro. Chemico-Biological Interactions 240, pages 110-118.
Crossref
Angelos Chatziavramidis, Zinovia Tsinaslanidou, Rozalia Valeri, Iordanis Konstantinidis & Jannis Constantinidis. (2015) Brush Cytology with Immunocytochemical Evaluation of VEGF Expression versus Biopsy in Clinically Precancerous Laryngeal Lesions: Can We Diagnose Laryngeal Cancer Only with Brush Cytology?. Analytical Cellular Pathology 2015, pages 1-7.
Crossref
Rodrigo Gonzalez Bonhin, Vanessa Brito Campoy Rocha, Guilherme Machado de Carvalho, Alexandre Caixeta Guimarães, Agrício Nubiato Crespo, Carlos Takahiro Chone & Eliane M.I. Amstalden. (2015) Correlation between vascular endothelial growth factor expression and presence of lymph node metastasis in advanced squamous cell carcinoma of the larynx. Brazilian Journal of Otorhinolaryngology 81:1, pages 58-62.
Crossref
Gino Marioni, Giancarlo Ottaviano, Marco Lionello, Elena Fasanaro, Claudia Staffieri, Luciano Giacomelli, Stefano Gattazzo, Alberto Staffieri & Stella Blandamura. (2014) A panel of biomarkers for predicting response to postoperative RT for laryngeal cancer?. American Journal of Otolaryngology 35:6, pages 771-778.
Crossref
A. Valenciano, L. A. Henríquez-Hernández, M. Lloret, B. Pinar & P. C. Lara. (2014) New biological markers in the decision of treatment of head and neck cancer patients. Clinical and Translational Oncology 16:10, pages 849-858.
Crossref
Marco Lionello, A. Lovato, A. Staffieri, S. Blandamura, C. Turato, L. Giacomelli, C. Staffieri & G. Marioni. (2013) The EGFR-mTOR pathway and laryngeal cancer angiogenesis. European Archives of Oto-Rhino-Laryngology 271:4, pages 757-764.
Crossref
Julie E. Bauman & Robert L. Ferris. (2014) Integrating novel therapeutic monoclonal antibodies into the management of head and neck cancer. Cancer 120:5, pages 624-632.
Crossref
Neil Gildener-Leapman, Robert L. Ferris & Julie E. Bauman. (2013) Promising systemic immunotherapies in head and neck squamous cell carcinoma. Oral Oncology 49:12, pages 1089-1096.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.